Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2010
08/19/2010WO2010047774A3 Inhibitors of mycobacterium tuberculosis malate synthase, methods of marking and uses thereof
08/19/2010US20100210837 Pactamycin biosynthetic gene cluster
08/19/2010US20100210663 Hybrid 2-Aminotetralin and Aryl-Substituted Piperazine Compounds and their Use in Altering CNS Activity
08/19/2010US20100210654 Novel p2y12 receptor antagonists
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210592 Amines or amino alcohols as glyt1 inhibitors
08/19/2010US20100210467 Agent for improving sugarcane brix and method of promoting sugarcane ripening using the same
08/19/2010CA2752190A1 Small molecule bradykinin b1 receptor antagonists
08/19/2010CA2751886A1 Novel amino azaheterocyclic carboxamides
08/18/2010EP2218713A1 Erlotinib hydrochloride polymorph Form A substantially free of polymorph Form B
08/18/2010EP2217575A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
08/18/2010EP2217234A2 Combinations of mek inhibitors with mtor inhibitors
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010CN101809002A morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101402609B Method for synthesis of 5-bromine-3-sec-butyl-6- methyl uracil
08/18/2010CN101323595B Synthetic method 1,2-dimethyl-1,4,5,6-tetrahydrochysene pyrimidine
08/17/2010US7777034 Crystalline ammonium salts of rosuvastatin
08/17/2010US7777032 N-4-[3-Chloro-4-(3-fluoro-benzyloxy)-phenyl]-N6-(3-ethyl-oxazolidin-2-ylidene)-quinazoline-4,6-diamine; use as type I receptor tyrosine kinase inhibitor; hyperproliferation diseases such as cancer; antiinflammatory agents
08/17/2010US7776906 Fungicidal active compound combinations
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776872 Diaminopyrimidines as P2X3 and P2X2/3 modulators
08/17/2010US7776871 for treatment of focal distonia, tremors, and parkinson's disease
08/17/2010US7776869 protein kinase modulators such as 3-((2-amino-5-pyrimidinyl)ethynyl)-4-methyl-N-(3-(trifluoromethyl)phenyl)benzamide, useful for the prophylaxis and treatment of inflammation, cancer, rheumatoid arthritis and for reducing blood flow in tumors
08/17/2010US7776866 Deuterium-enriched risperidone
08/17/2010US7776864 Fused bicyclic pyrimidines
08/17/2010CA2622794C Phenyl uracil stem/leaf desiccants
08/17/2010CA2605854C Novel pyridine derivative and pyrimidine derivative (3)
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/12/2010WO2010090304A1 Acylguanidine derivative
08/12/2010WO2010089943A1 Printing ink or toner containing dihydroperimidine squarylium compound, printed matter, method for detection of information, and method for ascertaining the genuineness of articles or substrates
08/12/2010WO2010089753A2 Novel polymorphs of lopinavir
08/12/2010WO2010054042A3 Dimethylphenoxy modulators of viral protease activity and/or parasitic enzyme activity
08/12/2010WO2010042489A3 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use
08/12/2010US20100204505 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
08/12/2010US20100204481 Compounds capable of activating cholinergic receptors
08/12/2010US20100204472 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/12/2010US20100204471 Mapk/erk kinase inhibitors
08/12/2010US20100204470 method for salt preparation
08/12/2010US20100204456 5-Fluoro-Uracil Immunoassay
08/12/2010US20100204234 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204206 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
08/12/2010US20100204182 Ectonucleotidase inhibitors
08/12/2010US20100204163 Metabolites and derivatives of ambrisentan
08/12/2010US20100199443 Yello anionic disazo dyes
08/11/2010EP2215066A1 Amide derivatives as sirtuin modulators
08/11/2010EP2215065A1 Ccr10 antagonists
08/11/2010EP2215049A1 P2x3, receptor antagonists for treatment of pain
08/11/2010EP2214486A1 Heteroaryl compounds and uses thereof
08/11/2010EP1699766B1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors
08/11/2010CN1938284B Chemical process
08/11/2010CN101801939A 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
08/11/2010CN101801937A Quinazolinone compounds and methods of use thereof
08/11/2010CN101801936A metabolites and derivatives of ambrisentan
08/11/2010CN101801935A uracil or thymine derivative for treating hepatitis c
08/11/2010CN101801931A Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
08/11/2010CN101801928A Novel herbicides
08/11/2010CN101798289A Method for preparing Erlotinib intermediate
08/11/2010CN101798288A Method for purifying pyrimidine compounds
08/11/2010CN101279950B 2-pyrimindinyloxy (pyrimindinylthio) benzoxy acetamide compound and application thereof
08/11/2010CN101279948B Synthetic method of 4,6- dichloro-5-(2-methoxyphenoxy)-2,2'-dipyridine
08/10/2010US7772395 diluting 2-[(4,6-Dimethoxypyrimidin-2-yl)methylthiomethyl]-6-methoxymethylaniline with glacial acetic acid and reacting with 30 to 35% aqueous hydrogen peroxide to form 2-[(4,6-dimethoxypyrimidin-2-yl)carbonyl]-6-methoxymethylaniline
08/10/2010US7772285 Benzophenone derivatives or salts thereof
08/10/2010US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
08/10/2010US7772244 Therapeutic agents for the treatment of migraine
08/10/2010US7772243 such as -Piperidin-1-yl-but-2-enoic acid [4(3-chloro-4-fluoro-phenylamino)-7-methoxy-quinazolin-6-yl]-amide, used as tyrosine kinase inhibitors, for the prevention of proliferative diseases, including cancer, atherosclerosis, restenosis, endometriosis and psoriasis
08/10/2010US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
08/10/2010US7772190 E.g., isobutyl N-methyl-N-trimethylallophanoyl-L-alanyl-D-lactate; using parasiticides and nematocides in medicine and veterinary medicine; productive and breeding animals; foods and feeds
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2334399C Uracil compounds and use thereof
08/05/2010WO2010088408A2 Subunit selective nmda receptor antagonists for the treatment of neurological conditions
08/05/2010WO2010088406A1 Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010086441A1 Pharmaceutical composition comprising n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
08/05/2010WO2010086438A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010WO2010059239A3 Lactate salt of 4-(6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197916 Diastereomeric purification of rosuvastatin
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197709 Non-sedating barbiturate compounds as neuroprotective agents
08/05/2010US20100197706 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics
08/05/2010US20100197705 Quinazolinone Derivatives Useful as Vanilloid Antagonists
08/05/2010US20100197696 Pesticidal heterocyclic dihaloallyl compounds
08/05/2010US20100197680 Lactam-substituted dicarboxylic acids and use thereof
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197655 Sulfonamide derivatives
08/05/2010DE102009006643A1 Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten Preparation of halogenated N-heteroaromatic Polyhalogenderivaten
08/05/2010CA2750801A1 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2213665A1 Erlotinib hydrochloride
08/04/2010EP2213664A1 Process for the preparation of cyclopenta[g]quinazoline derivatives
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 427